United States S 3271: Fairness in Orphan Drug Exclusivity Act

Status: Introduced in Senate (as of 2020-02-11)

State: United States · Session: 116 · Bill: S 3271

Subjects: Competition and antitrust, Drug safety, medical device, and laboratory regulation, Licensing and registrations, Marketing and advertising, Prescription drugs

Sponsors: Bill Cassidy, Jeanne Shaheen, Tammy Baldwin

View United States S 3271 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.